Search

Scott Richard Sacane

from Weston, CT
Age ~57

Scott Sacane Phones & Addresses

  • 5 Hills End Ln, Weston, CT 06883 (203) 226-3678
  • 6 Woods End Ln, Weston, CT 06883 (203) 226-3678
  • Wilton, CT
  • New York, NY
  • Boston, MA
  • Norwalk, CT
  • Newmarket, NH
  • Calais, VT
  • Summerfield, FL

Resumes

Resumes

Scott Sacane Photo 1

Founder, Chief Executive Officer

View page
Location:
5 Hills End Ln, Weston, CT 06883
Industry:
Biotechnology
Work:
Catalytic Data Inc. since 2010
President, CEO
Education:
University of Colorado at Boulder 1984 - 1988
Skills:
Start Ups
Biotechnology
Genomics
Drug Discovery
Molecular Biology
Genetics
Bioinformatics
Biochemistry
Cancer
Biopharmaceuticals
Life Sciences
Cell Biology
Lifesciences
Drug Development
Protein Chemistry
Strategic Planning
Data Mining
Corporate Development
Cross Functional Team Leadership
Immunology
Saas
Stem Cells
Clinical Trials
Gene Therapy
Protein Purification
Proteomics
Science
Research
Interests:
Cu Buffalo Football
Crowdsourcing
Fly Fishing
Skiing
Open Science
Ny Yankee Baseball
Scott Sacane Photo 2

Founder, Chief Executive Officer

View page
Location:
New York, NY
Work:

Founder, Chief Executive Officer
Interests:
Crowdsourcing
Fly Fishing
Skiing
Open Science
Scott Sacane Photo 3

Scott Sacane

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Scott Sacane
CEO
CATALYTIC IP INCORPORATED
2 Hollyhock Rd, Wilton, CT 06897
5 Hl End Ln, Weston, CT 06883
2 Hollyhock Ln, Wilton, CT 06897
5 Hl End Rd, Weston, CT 06883
Scott R. Sacane
Manager
ENDPOINT ADVISORS LLC
Business Services at Non-Commercial Site
5 Hl End Rd, Weston, CT 06883
5 Hl End Ln, Weston, CT 06883

Publications

Us Patents

Chemorepulsion Of Cells

View page
US Patent:
20100203087, Aug 12, 2010
Filed:
Feb 2, 2010
Appl. No.:
12/698732
Inventors:
Hyun Kang - Belmont MA, US
Scott Sacane - Weston CT, US
Jonathan L. Moon - Decatur GA, US
Erica B. Goodhew - Atlanta GA, US
Lopa Bhatt - Roswell GA, US
Stacey L. Rose - Atlanta GA, US
Milton H. Werner - Marietta GA, US
International Classification:
A61K 45/00
C12N 5/071
C12Q 1/02
A61P 29/00
US Classification:
4242781, 435366, 4353722, 4353723, 435 29
Abstract:
The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes.

Chemorepulsion Of Cells

View page
US Patent:
20080213319, Sep 4, 2008
Filed:
Oct 4, 2007
Appl. No.:
11/867290
Inventors:
Hyun Kang - Belmont MA, US
Scott Sacane - Weston CT, US
Jonathan L. Moon - Decatur GA, US
Erica B. Goodhew - Atlanta GA, US
Lopa Bhatt - Roswell GA, US
Stacey L. Rose - Atlanta GA, US
Milton H. Werner - Marietta GA, US
International Classification:
A61K 39/085
C12Q 1/02
A61K 38/16
A61K 31/739
A61K 31/352
A61K 31/045
A61K 31/337
A61P 37/02
US Classification:
4242821, 435 29, 514 12, 514 62, 514733, 514449, 514456
Abstract:
The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes.

Chemorepulsion Of Cells

View page
US Patent:
20180022793, Jan 25, 2018
Filed:
Apr 6, 2017
Appl. No.:
15/480884
Inventors:
- Atlanta GA, US
Scott Sacane - Weston CT, US
Jonathan L. Moon - Decatur GA, US
Erica B. Goodhew - Atlanta GA, US
Lopa Bhatt - Roswell GA, US
Stacey L. Rose - Atlanta GA, US
Milton H. Werner - Marietta GA, US
International Classification:
C07K 16/18
A61K 31/352
A61K 31/739
G01N 33/50
A61K 31/045
A61K 38/17
A61K 38/57
A61K 31/337
Abstract:
The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes.
Scott Richard Sacane from Weston, CT, age ~57 Get Report